| Biomarker ID | 1547 |
| PMID | 25248617 |
| Year | 2014 |
| Biomarker | STEAP2 (Six transmembrane epithelial antigen of the prostate) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in DU145 and PC3 (28 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: TGF-beta regulation of extracellular matrix, T cell receptor regulation of apoptosis |
| Experiment | Cancerous Vs Non Cancerous Cell Lines |
| Type of Biomarker | Diagnostic |
| Cohort | PNT2 (Normal Prostate epithelial cell line), and Cancerous: DU145 and PC3 were used for this experiment |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | Western Blotting |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on Human Patient Cohort |
| Technical Name | NA |